Seer (NASDAQ:SEER) Shares Down 2.7%

Seer, Inc. (NASDAQ:SEER)’s stock price was down 2.7% during mid-day trading on Monday . The stock traded as low as $1.77 and last traded at $1.79. Approximately 1,043,092 shares traded hands during trading, an increase of 131% from the average daily volume of 451,460 shares. The stock had previously closed at $1.84.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley restated an “equal weight” rating and set a $7.00 target price on shares of Seer in a research report on Tuesday, March 5th.

Seer Stock Down 2.7 %

The company has a market cap of $115.94 million, a P/E ratio of -1.32 and a beta of 1.65. The business’s 50 day moving average is $1.81 and its 200 day moving average is $1.79.

Seer (NASDAQ:SEER) last issued its quarterly earnings data on Thursday, February 29th. The company reported ($0.28) EPS for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.07. The company had revenue of $4.44 million during the quarter, compared to the consensus estimate of $4.24 million. Seer had a negative net margin of 517.84% and a negative return on equity of 20.87%. As a group, equities research analysts forecast that Seer, Inc. will post -1.22 EPS for the current year.

Insider Transactions at Seer

In other Seer news, CEO Omid Farokhzad sold 52,857 shares of the company’s stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $2.03, for a total value of $107,299.71. Following the sale, the chief executive officer now directly owns 1,436,285 shares of the company’s stock, valued at $2,915,658.55. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Over the last three months, insiders have sold 69,149 shares of company stock valued at $133,366. Corporate insiders own 15.02% of the company’s stock.

Institutional Investors Weigh In On Seer

Several hedge funds have recently modified their holdings of the company. Virtu Financial LLC acquired a new position in shares of Seer during the 4th quarter worth about $28,000. GSA Capital Partners LLP purchased a new position in Seer in the 4th quarter worth approximately $32,000. Tower Research Capital LLC TRC lifted its stake in Seer by 185.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 8,737 shares of the company’s stock worth $37,000 after purchasing an additional 5,672 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new position in Seer in the 2nd quarter worth approximately $48,000. Finally, UBS Group AG lifted its stake in Seer by 286.7% in the 3rd quarter. UBS Group AG now owns 6,389 shares of the company’s stock worth $49,000 after purchasing an additional 4,737 shares in the last quarter. 75.20% of the stock is owned by hedge funds and other institutional investors.

About Seer

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.